These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 34416271)
1. Characterization of Polysorbate 80 by Liquid Chromatography-Mass Spectrometry to Understand Its Susceptibility to Degradation and Its Oxidative Degradation Pathway. Liu H; Jin Y; Menon R; Laskowich E; Bareford L; de Vilmorin P; Kolwyck D; Yeung B; Yi L J Pharm Sci; 2022 Feb; 111(2):323-334. PubMed ID: 34416271 [TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Assessment of All-Oleate Polysorbate 80: Free Fatty Acid Particle Formation, Interfacial Protection and Oxidative Degradation. Doshi N; Giddings J; Luis L; Wu A; Ritchie K; Liu W; Chan W; Taing R; Chu J; Sreedhara A; Kannan A; Kei P; Shieh I; Graf T; Hu M Pharm Res; 2021 Mar; 38(3):531-548. PubMed ID: 33713012 [TBL] [Abstract][Full Text] [Related]
3. What Makes Polysorbate Functional? Impact of Polysorbate 80 Grade and Quality on IgG Stability During Mechanical Stress. Grabarek AD; Bozic U; Rousel J; Menzen T; Kranz W; Wuchner K; Jiskoot W; Hawe A J Pharm Sci; 2020 Jan; 109(1):871-880. PubMed ID: 31614127 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Polysorbate 80 Hydrolysis and Oxidation on the Aggregation of a Monoclonal Antibody. Larson NR; Wei Y; Prajapati I; Chakraborty A; Peters B; Kalonia C; Hudak S; Choudhary S; Esfandiary R; Dhar P; Schöneich C; Middaugh CR J Pharm Sci; 2020 Jan; 109(1):633-639. PubMed ID: 31758949 [TBL] [Abstract][Full Text] [Related]
5. Factors Influencing Polysorbate's Sensitivity Against Enzymatic Hydrolysis and Oxidative Degradation. Kranz W; Wuchner K; Corradini E; Berger M; Hawe A J Pharm Sci; 2019 Jun; 108(6):2022-2032. PubMed ID: 30639738 [TBL] [Abstract][Full Text] [Related]
6. 4-Hydroxynonenal is An Oxidative Degradation Product of Polysorbate 80. Schröter A; Koulov AV; Huwyler J; Mahler HC; Jahn M J Pharm Sci; 2021 Jun; 110(6):2524-2530. PubMed ID: 33545186 [TBL] [Abstract][Full Text] [Related]
7. Detailed profiling of polysorbate 80 oxidative degradation products and hydrolysates using liquid chromatography-tandem mass spectrometry analysis. Konya Y; Ochiai R; Fujiwara S; Tsujino K; Okumura T Rapid Commun Mass Spectrom; 2024 Apr; 38(7):e9715. PubMed ID: 38351644 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic understanding of metal-catalyzed oxidation of polysorbate 80 and monoclonal antibody in biotherapeutic formulations. Bensaid F; Dagallier C; Authelin JR; Audat H; Filipe V; Narradon C; Guibal P; Clavier S; Wils P Int J Pharm; 2022 Mar; 615():121496. PubMed ID: 35074436 [TBL] [Abstract][Full Text] [Related]
10. Profiling polysorbate 80 components using comprehensive liquid chromatography-tandem mass spectrometry analysis. Konya Y; Ochiai R; Fujiwara S; Tsujino K; Okumura T Rapid Commun Mass Spectrom; 2023 Mar; 37(6):e9438. PubMed ID: 36410723 [TBL] [Abstract][Full Text] [Related]
11. Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability. Tomlinson A; Zarraga IE; Demeule B Mol Pharm; 2020 Jul; 17(7):2345-2353. PubMed ID: 32442382 [TBL] [Abstract][Full Text] [Related]
12. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry. Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737 [TBL] [Abstract][Full Text] [Related]
13. Development of UPLC-UV-ELSD Method for Fatty Acid Profiling in Polysorbate 80 and Confirmation of the Presence of Conjugated Fatty Acids by Mass Spectrometry, UV Absorbance and Proton Nuclear Magnetic Resonance Spectroscopy. Doyle M; Barnes A; Larson NR; Liu H; Yi L J Pharm Sci; 2023 Sep; 112(9):2393-2403. PubMed ID: 37295606 [TBL] [Abstract][Full Text] [Related]
14. Ester hydrolysis of polysorbate 80 in mAb drug product: evidence in support of the hypothesized risk after the observation of visible particulate in mAb formulations. Labrenz SR J Pharm Sci; 2014 Aug; 103(8):2268-77. PubMed ID: 24942482 [TBL] [Abstract][Full Text] [Related]
15. Micelle Driven Oxidation Mechansim and Novel Oxidation Markers for Different Grades of Polysorbate 20 and 80. Kranz W; Wuchner K; Corradini E; Menzen T; Hawe A J Pharm Sci; 2020 Oct; 109(10):3064-3077. PubMed ID: 32653599 [TBL] [Abstract][Full Text] [Related]
16. Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations. Hall T; Sandefur SL; Frye CC; Tuley TL; Huang L J Pharm Sci; 2016 May; 105(5):1633-1642. PubMed ID: 27056628 [TBL] [Abstract][Full Text] [Related]
17. The Characterization of Polysorbate. Zhang S; Xiao H; Li N Curr Protoc; 2022 Jul; 2(7):e489. PubMed ID: 35857882 [TBL] [Abstract][Full Text] [Related]
18. Rapid Polysorbate 80 Degradation by Liver Carboxylesterase in a Monoclonal Antibody Formulated Drug Substance at Early Stage Development. Zhang S; Xiao H; Molden R; Qiu H; Li N J Pharm Sci; 2020 Nov; 109(11):3300-3307. PubMed ID: 32721471 [TBL] [Abstract][Full Text] [Related]
19. High throughput multidimensional liquid chromatography approach for online protein removal and characterization of polysorbates and poloxamer in monoclonal antibody formulations. Zegota MM; Schuster G; De Pra M; Müllner T; Menzen T; Steiner F; Hawe A J Chromatogr A; 2024 Apr; 1720():464777. PubMed ID: 38432108 [TBL] [Abstract][Full Text] [Related]
20. On-line coupling of hydrophobic interaction column with reverse phase column -charged aerosol detector/mass spectrometer to characterize polysorbates in therapeutic protein formulations. He Y; Brown P; Bailey Piatchek MR; Carroll JA; Jones MT J Chromatogr A; 2019 Feb; 1586():72-81. PubMed ID: 30551943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]